Peptidoglycan pathways: there are still more!
- PMID: 35530449
- PMCID: PMC9071014
- DOI: 10.1039/c9ra04518j
Peptidoglycan pathways: there are still more!
Abstract
The discovery of 3rd and 4th generations of currently existing classes of antibiotics has not hindered bacterial resistance, which is escalating at an alarming global level. This review follows WHO recommendations through implementing new criteria for newly discovered antibiotics. These recommendations focus on abandoning old scaffolds and hitting new targets. In light of these recommendations, this review discusses seven bacterial proteins that no commercial antibiotics have targeted yet, alongside their reported chemical scaffolds.
This journal is © The Royal Society of Chemistry.
Conflict of interest statement
There are no conflicts to declare.
Figures











Similar articles
-
New antibiotics from bacterial natural products.Nat Biotechnol. 2006 Dec;24(12):1541-50. doi: 10.1038/nbt1266. Nat Biotechnol. 2006. PMID: 17160060 Review.
-
Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence.Acc Chem Res. 2021 Apr 20;54(8):1866-1877. doi: 10.1021/acs.accounts.1c00007. Epub 2021 Mar 18. Acc Chem Res. 2021. PMID: 33733746 Free PMC article.
-
Unconventional Antibacterials and Adjuvants.Acc Chem Res. 2021 Feb 16;54(4):917-929. doi: 10.1021/acs.accounts.0c00776. Epub 2021 Jan 29. Acc Chem Res. 2021. PMID: 33512995 Free PMC article.
-
Novel Targets of Antimicrobial Therapies.Microbiol Spectr. 2016 Apr;4(2). doi: 10.1128/microbiolspec.VMBF-0018-2015. Microbiol Spectr. 2016. PMID: 27227296 Review.
-
Development of Whole-Cell Biosensors for Screening of Peptidoglycan-Targeting Antibiotics in a Gram-Negative Bacterium.Appl Environ Microbiol. 2022 Sep 22;88(18):e0084622. doi: 10.1128/aem.00846-22. Epub 2022 Aug 30. Appl Environ Microbiol. 2022. PMID: 36040151 Free PMC article.
Cited by
-
Triazole-functionalized compounds as promising antifungal agents: Synthesis, biological evaluation, and mechanistic insights.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 13. doi: 10.1007/s00210-025-04350-1. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40512216
-
Rational design and synthesis of novel phenyltriazole derivatives targeting MRSA cell wall biosynthesis.RSC Adv. 2024 Dec 20;14(54):39977-39994. doi: 10.1039/d4ra07367c. eCollection 2024 Dec 17. RSC Adv. 2024. PMID: 39713184 Free PMC article.
-
Phenyltriazole-based sulfonamides: novel dual-target agents against MRSA biofilms and resistant pathogens.RSC Adv. 2025 Jun 17;15(22):17186-17202. doi: 10.1039/d5ra02412a. eCollection 2025 May 21. RSC Adv. 2025. PMID: 40529822 Free PMC article.
References
-
- WHO, Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including tuberculosis, World Health Organization, Geneva, 2017, WHO/EMP/IAU/2017.11
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous